We performed a systematic review of Cochrane, EMBASE, and MEDLINE databases to identify randomized controlled trials comparing QLB and TAPB in patients undergoing inguinal hernia repair. Outcomes included postoperative pain and opioid consumption. Statistical analysis was performed using RevMan 5.4. The review protocol was registered at PROSPERO (CRD42023445513).
We included five RCTs encompassing 255 patients. QLB was associated with a significant decrease in postoperative pain (MD -0.45; 95% CI -0.75 to -0.14; and p = 0.004; I2 = 94%). However, we found no difference in 24-h opioid consumption between QLB and TAPB groups.
QLB may offer superior pain reduction. However, its effect on opioid consumption remains unclear.
方法:我们对Cochrane,EMBASE,和MEDLINE数据库,以确定比较接受腹股沟疝修补术患者QLB和TAPB的随机对照试验。结果包括术后疼痛和阿片类药物消耗。使用RevMan5.4进行统计分析。审查方案在PROSPERO(CRD42023445513)注册。
结果:我们纳入了5个RCT,包括255名患者。QLB与术后疼痛显著减轻相关(MD-0.45;95%CI-0.75至-0.14;p=0.004;I2=94%)。然而,我们发现QLB组和TAPB组的24小时阿片类药物用量无差异.
结论:QLB可以提供更好的疼痛减轻。然而,其对阿片类药物消费的影响尚不清楚.